As part of a planned multicenter long-term study on ceramic implantology, fundamental scientific and clinical questions will be systematically investigated in the coming years. The goal is to close existing evidence gaps—particularly regarding the prevalence of peri-implant diseases associated with ceramic implants—and to establish a solid scientific foundation for future clinical recommendations.

A key initial step will be the precise definition of fundamental terminologies and classifications such as one-piece, two-piece, split, reversibly screw-retained, cemented, bone-level, tissue-level, or submerged. This terminological harmonization forms the prerequisite for valid and intersystemically comparable data collection and thereby establishes the methodological foundation for meaningful analysis.

The study protocol will be designed to comply with regulatory requirements in accordance with Post-Market Clinical Follow-up (PMCF) and Post-Market Surveillance (PMS). In close collaboration with internationally leading universities, research groups, and clinical centers, the final protocol will be developed in the coming months and adopted during the 2026 Consensus Conference.

The advantage of this structured approach lies in the high relevance and sustainability of the resulting data structure. The results of this study aim to create a transparent and reliable evidence base—for clinicians, patients, academic institutions, and implant manufacturers alike. On this foundation, future consensus conferences and guideline developments will be able to rely on robust and comparable data.

Through methodological standardization, research activities will no longer lose scientific significance due to a lack of comparability. This will significantly improve efficiency, relevance, and resource utilization in both clinical and preclinical research.

The precise definition of system classifications will, for the first time, enable direct comparison between different ceramic implant systems. In this way, within just a few years, a data foundation can be established that matches or even surpasses the current evidence level of titanium implantology in terms of quality and significance.

A decisive advantage of the current situation lies in the more than 25 years of clinical experience with ceramic implants. Given the limited number of active manufacturers currently in the market, there is now a unique opportunity to bring these key players together at one table and realize a coordinated, scientifically grounded, and cross-industry research project.

In doing so, a strong foundation will be created for the future of ceramic implantology—with the goal of uniting scientific evidence, clinical experience, and industrial responsibility into a shared, transparent basis for the next generation of dental implantology.